Related Experiment Video
Updated: Jul 16, 2025

03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.1K
Development of Electronic Health Record-Based Machine Learning Models to Predict Barrett's Esophagus and Esophageal
Prasad G Iyer1, Karan Sachdeva1, Cadman L Leggett1
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Clinical and Translational Gastroenterology
|September 12, 2023
Summary
Machine learning models accurately predict Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) risk using electronic health records. This approach may improve screening for these conditions.
Area of Science:
- Gastroenterology
- Oncology
- Medical Informatics
Background:
- Screening for Barrett's esophagus (BE) is recommended for individuals with risk factors but is underutilized.
- Existing risk prediction tools for BE and esophageal adenocarcinoma (EAC) have modest accuracy (AUROC ≤0.7) and face implementation challenges.
Purpose of the Study:
- To develop and evaluate machine learning (ML) models for predicting BE and EAC risk using a large electronic health record (EHR) database.
Main Methods:
- Utilized a deidentified EHR database from 6 million patients.
- Identified BE and EAC cases and controls using ICD codes and natural language processing on clinical notes.
- Employed an ensemble transformer-based ML model architecture.
Main Results:
- The BE ML model achieved 76% sensitivity, 76% specificity, and 0.84 AUROC.
- The EAC ML model achieved 84% sensitivity, 70% specificity, and 0.84 AUROC.
- Identified novel risk predictors including coronary artery disease, serum triglycerides, and electrolytes.
Conclusions:
- ML models trained on EHR data demonstrate superior accuracy in predicting BE and EAC risk compared to traditional methods.
- These models hold potential for enhancing the clinical implementation of minimally invasive screening technologies for BE and EAC.
Related Concept Videos
Barrett Esophagus-I: Introduction
122
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
122
Barrett Esophagus-II: Clinical Manifestations and Management
191
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
191

